Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Michael Sharma"'
Autor:
Cheryl Symington, Monica Taljaard, Jamie C. Brehaut, Ian G. Stiell, Jeffrey J. Perry, Marlène Mansour, Michael Sharma
Publikováno v:
Stroke. 41:987-991
Background and Purpose— Four percent to 10% of patients with transient ischemic attack (TIA) have a stroke or die within 1 week of their diagnosis. This national survey examined Canadian neurologists’ current practice for managing TIA, the need f
Autor:
Kumanan Wilson, Brian Hutton, Michael Sharma, D. William Cameron, Alan Tinmouth, Dean Fergusson, Paul C. Hébert
Publikováno v:
Scopus-Elsevier
BACKGROUND: Given the increasing use of intravenous immunoglobulin (IVIG) for various neurologic conditions and uncertainty pertaining to its benefits and harms, a systematic review was conducted of randomized controlled trials (RCTs) evaluating IVIG
Publikováno v:
Stroke. 44:2617-2619
Background and Purpose— The determinants of satisfaction for families of acute stroke patients receiving palliative care have not been extensively studied. We surveyed families to determine how they perceived palliative care after stroke. Methods
Autor:
Cristian Sharma, Donna Stanton, Maulik Jain, Jay Sharma, karl kramberger, Karina Amezcua, Jitesh P. Jani, Michael Sharma, Rubio Punzalan, Douglas N. Foster, Satya Narayan, Reed Hasson, Natalee Amezcua, Miriam Navel
Publikováno v:
Cancer Research. 77:3889-3889
Pancreatic cancer is the fourth leading cause of cancer mortality in the US, despite significant improvements in diagnostic imaging and operative mortality rates. The 5-year survival rate remains less than 6% because of microscopic or gross metastati
Autor:
Tim Hartley, Michael Sharma, Grace Parraga, J. David Spence, Robert D. Reid, Peter L. Prior, Neville Suskin, Damien Pike, D. Buchanan, Richard Chan, Tamas J Lindenmaier
Publikováno v:
Medical Biophysics Publications
Cardiovascular Ultrasound
Cardiovascular Ultrasound
BACKGROUND: It is still not known how patients who are post-transient ischemic attack (TIA) or post-stroke might benefit from prospectively planned comprehensive cardiac rehabilitation (CCR). In this pilot evaluation of a larger ongoing randomized-co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3c7a2b4d75c57bc305184517a73d474
https://ir.lib.uwo.ca/context/biophysicspub/article/1097/viewcontent/TJ_Lindenmaier_Nov_2013_CardUS.pdf
https://ir.lib.uwo.ca/context/biophysicspub/article/1097/viewcontent/TJ_Lindenmaier_Nov_2013_CardUS.pdf
Autor:
Michael W. Nicolle, Donald H. Lee, Michael Sharma, Alicia Mattia, J. Alexander Fraser, Robert Hammond
Publikováno v:
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 40(5)
Publikováno v:
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 40(4)
Background:Current recommendations for carotid endarterectomy (CEA) for symptomatic carotid stenosis state benefit is greatest when performed within two weeks of symptoms. However, only a minority of cases are operated on within this guideline, and n
Abstract WP120: Granuloctye-Colony Stimulating Factor in Ischemic Stroke Trial (GIST): A Pilot Study
Autor:
Michael Sharma, David Gladstone, Sandra Black, Dylan Blacquiere, Matthew Hogan, Grant Stotts, Lisa Walker, Harry Atkins
Publikováno v:
Stroke. 44
Introduction: Granulocyte-colony stimulating factor (G-CSF) is upregulated in models of cerebral ischemia. This may promote hematopoietic stem cell (HSC) mediated central nervous system repair. We hypothesize that exogenous G-CSF may promote recovery
Autor:
Donna Stanton, Cristian Sharma, Robert Rodriguez, Sherven Sharma, Natalee Amezcua, Mandana Amiri, S. C. Sharma, Padmini Narayanan, Jitesh P. Jani, Miriam Navel, Michael Sharma, Jay Sharma
Publikováno v:
Cancer Research. 76:1723-1723
Despite improvements in treatment modalities, pancreatic cancer remains the fourth leading cause of cancer mortality in the US. The 5-year survival rate is less than 6% because of the extent of metastases at the time of diagnosis. The treatment of pa
Autor:
Michael Sharma, Sonja V. Sorensen, Anuraag R. Kansal, Siyang Peng, Neil Roskell, Brigitta U. Monz, Andreas Clemens, Carole Bradley-Kennedy
Publikováno v:
Thrombosis and haemostasis. 108(4)
SummaryCanadian patients with atrial fibrillation (AF) in whom anticoagulation is appropriate have two new choices for anticoagulation for prevention of stroke and systemic embolism – dabigatran etexilate (dabigatran) and rivaroxaban. Based on the